Group | Variable | Trial | Rest | 3 min post test | 1 h post test |
---|---|---|---|---|---|
PLA | FRAP (μmol TE/l) | 1st | 807.5 ± 39.2 | 865.6 ± 35.9 | 945.6 ± 46.0† |
2nd | 1000.2 ± 75.5** | 1036.7 ± 74.5** | 1093.2 ± 61.8**† | ||
GTE | 1st | 805.7 ± 108.2 | 887.8 ± 132.9 | 901.7 ± 156.3 | |
2nd | 1166.1 ± 63.6*** | 1210.6 ± 57.5*** | 1308.1 ± 101.5***†† | ||
PLA | TBARS (μmol /l) | 1st | 4.72 ± 0.6 | 5.30 ± 0.5 | 4.65 ± 0.7 |
2nd | 6.28 ± 0.6** | 6.98. ± 1.2** | 6.19 ± 0.9** | ||
GTE | 1st | 4.77 ± 0.7 | 5.16 ± 0.5 | 4.47 ± 0.7 | |
2nd | 4.14 ± 0.6 | 4.92 ± 0.9 | 3.69 ± 0.6 | ||
PLA | BDNF (ng/ml) | 1st | 9.97 ± 2.6 | 12.24 ± 1.9†† | 11.47 ± 1.8† |
2nd | 11.02 ± 2.6 | 12.00 ± 2.2 | 11.71 ± 1.4 | ||
GTE | 1st | 10.78 ± 2.4 | 11.73 ± 2.5 | 11.31 ± 2.2 | |
2nd | 12.79 ± 2.1 | 13.19 ± 1.9 | 12.95 ± 1.7 |